This edition of the Genetic Technology TOE depicts trends across biopharmaceuticals. High-throughput microbial analysis, epigenetic therapies, and targeted drug discovery are profiled through recent innovations. The corresponding clinical trials scenario for acromegaly is also depicted.
The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: High-throughput microbial analysis, epigenetic therapy, autism spectrum disorder, targeted therapy, endocrine diseases, targeted formulation, dermatology, acromegaly
1. Innovations Leading the Biotech Landscape
Recent Biotech and Biopharma Advances
- High-throughput Microbial Analysis
- Epigenetic Therapy for Autism Spectrum Disorder (ASD)
- Targeted Therapy for Endocrine Diseases and Endocrine Cancer
- Targeted Formulation for Dermatological Indications
Clinical Trial Analysis and Industry Interactions
- Clinical Trial Analysis for Acromegaly
- Key Contacts